低分子量肝素用于髋关节手术的院外预防：法国研究——35天时的静脉造影结果 - Suppr | 超能文献

Out-of-hospital prophylaxis with low-molecular-weight heparin in hip surgery: the French study--venographic outcome at 35 days.

作者信息

Planes A, Vochelle N, Darmon J Y

机构信息

Clinique Radio-Chirurgicale du Mail, La Rochelle, France.

出版信息

Chest. 1998 Aug;114(2 Suppl Evidence):125S-129S. doi: 10.1378/chest.114.2_supplement.125s.

DOI:10.1378/chest.114.2_supplement.125s

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Out-of-hospital prophylaxis with low-molecular-weight heparin in hip surgery: the French study--venographic outcome at 35 days.低分子量肝素用于髋关节手术的院外预防：法国研究——35天时的静脉造影结果

Chest. 1998 Aug;114(2 Suppl Evidence):125S-129S. doi: 10.1378/chest.114.2_supplement.125s.

2

The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group.低剂量依诺肝素预防下肢关节置换术后有症状静脉血栓栓塞的发生率：一项对1984例患者的队列研究。加拿大协作组。

Chest. 1998 Aug;114(2 Suppl Evidence):115S-118S. doi: 10.1378/chest.114.2_supplement.115s.

3

Out-of-hospital prophylaxis with low-molecular-weight heparin in hip surgery: the Swedish study.髋关节手术中低分子量肝素的院外预防：瑞典的研究。

Chest. 1998 Aug;114(2 Suppl Evidence):130S-132S. doi: 10.1378/chest.114.2_supplement.130s.

4

Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.低分子量肝素（依诺肝素）与普通肝素在髋关节置换术患者预防深静脉血栓形成和肺栓塞中的比较。

Ann Chir Gynaecol. 1995;84(1):85-90.

5

Antithromboembolic efficacy and safety of enoxaparin in general surgery. German multicentre trial.依诺肝素在普通外科中的抗血栓栓塞疗效及安全性。德国多中心试验。

Eur J Surg Suppl. 1994(571):37-43.

6

Ultrasonographic screening for deep vein thrombosis following arthroplasty fails to reduce posthospital thromboembolic complications: the Postarthroplasty Screening Study (PASS).关节置换术后超声筛查深静脉血栓形成并不能降低出院后血栓栓塞并发症的发生率：关节置换术后筛查研究（PASS）。

Chest. 1998 Aug;114(2 Suppl Evidence):119S-122S. doi: 10.1378/chest.114.2_supplement.119s.

7

Cost-effectiveness of prolonged out-of-hospital prophylaxis with low-molecular-weight heparin following total hip replacement.

Haemostasis. 2000;30 Suppl 2:130-5; discussion 128-9. doi: 10.1159/000054179.

8

A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.低分子量肝素与双氢麦角胺固定剂量组合对比调整剂量普通肝素预防全髋关节置换术后深静脉血栓形成的研究

Thromb Haemost. 1996 Feb;75(2):246-50.

9

Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean?下肢关节置换术后的延长血栓预防：临床试验意味着什么？

Haemostasis. 2000;30 Suppl 2:88-94; discussion 82-3. doi: 10.1159/000054171.

10

Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.依诺肝素预防大手术后深静脉血栓形成：多中心研究。意大利研究小组。

Int Surg. 1993 Jul-Sep;78(3):271-5.

引用本文的文献

1

Thromboprophylaxis in Head and Neck Microvascular Reconstruction.头颈部微血管重建中的血栓预防

Craniomaxillofac Trauma Reconstr. 2018 Jun;11(2):85-95. doi: 10.1055/s-0037-1607068. Epub 2017 Oct 31.

2

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.延长疗程的抗凝剂用于预防全髋关节或膝关节置换术后或髋部骨折修复后的静脉血栓栓塞。

Cochrane Database Syst Rev. 2016 Mar 30;3(3):CD004179. doi: 10.1002/14651858.CD004179.pub2.